Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P G Dyment

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Acta Dermato-Venereologica|January 1, 1978
Histiocytic medullary reticulosis presenting as Mucha-Habermann diseaseM J Freeman, J S Taylor, H S Levin, et al.
Cancer Chemotherapy Reports|March 1, 1975
Combined chemotherapy in childhood rhabdomyosarcomaD J Pullen, P G Dyment, G B Hymphrey, et al.
Bulletin of Environmental Contamination and Toxicology|September 1, 1971
Relationship between levels of chlorinated hydrocarbon insecticides in human milk and serumP G Dyment, L M Hebertson, W J Decker, et al.
Medical and Pediatric Oncology|January 1, 1979
Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in childrenJ Herson, K A Starling, P G Dyment, et al.
The Journal of Bone and Joint Surgery. American Volume|July 1, 1976
Multidrug chemotherapy in pulmonary treatment of osteosarcomaW W Sutow, E A Gehan, T J Vietti, et al.
The Physician and Sportsmedicine|July 23, 2016
ForumM Stiegler, J Blankenship, D P Stark, et al.
Cancer Treatment Reports|August 1, 1979
ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group studyP G Dyment, K A Starling, V J Land, et al.
Medical and Pediatric Oncology|January 1, 1976
Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemiaV J Land, W W Sutow, P G Dyment, et al.
Cancer Chemotherapy Reports|September 1, 1973
5-Fluorouracil (NSC-19893) and actinomycin D (NSC-3053) in the treatment of acute leukemic in childrenV J Land, P G Dyment, D Komp, et al.
Medical and Pediatric Oncology|January 1, 1984
Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Acta Dermato-Venereologica|January 1, 1978
Histiocytic medullary reticulosis presenting as Mucha-Habermann diseaseM J Freeman, J S Taylor, H S Levin, et al.
Cancer Chemotherapy Reports|March 1, 1975
Combined chemotherapy in childhood rhabdomyosarcomaD J Pullen, P G Dyment, G B Hymphrey, et al.
Bulletin of Environmental Contamination and Toxicology|September 1, 1971
Relationship between levels of chlorinated hydrocarbon insecticides in human milk and serumP G Dyment, L M Hebertson, W J Decker, et al.
Medical and Pediatric Oncology|January 1, 1979
Vincristine and prednisone vs vincristine, L-asparaginase, and prednisone for second remission induction of acute lymphocytic leukemia in childrenJ Herson, K A Starling, P G Dyment, et al.
The Journal of Bone and Joint Surgery. American Volume|July 1, 1976
Multidrug chemotherapy in pulmonary treatment of osteosarcomaW W Sutow, E A Gehan, T J Vietti, et al.
The Physician and Sportsmedicine|July 23, 2016
ForumM Stiegler, J Blankenship, D P Stark, et al.
Cancer Treatment Reports|August 1, 1979
ICRF-159 (razoxane) in the treatment of pediatric solid tumors: a Southwest Oncology Group studyP G Dyment, K A Starling, V J Land, et al.
Medical and Pediatric Oncology|January 1, 1976
Remission induction with L-asparaginase, vincristine, and prednisone in children with acute nonlymphoblastic leukemiaV J Land, W W Sutow, P G Dyment, et al.
Cancer Chemotherapy Reports|September 1, 1973
5-Fluorouracil (NSC-19893) and actinomycin D (NSC-3053) in the treatment of acute leukemic in childrenV J Land, P G Dyment, D Komp, et al.
Medical and Pediatric Oncology|January 1, 1984
Impact of the timing of triple intrathecal therapy on remission induction in childhood acute lymphoblastic leukemia: a Pediatric Oncology Group studyE Hvizdala, D H Berry, T Chen, et al.
Pageof 7